These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 24735529)

  • 1. Association of genetic variation of sodium taurocholate cotransporting polypeptide with chronic hepatitis B virus infection.
    Li N; Zhang P; Yang C; Zhu Q; Li Z; Li F; Han Q; Wang Y; Lv Y; Wei P; Liu Z
    Genet Test Mol Biomarkers; 2014 Jun; 18(6):425-9. PubMed ID: 24735529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of NTCP polymorphisms with clinical outcome of hepatitis B infection in Thai individuals.
    Chuaypen N; Tuyapala N; Pinjaroen N; Payungporn S; Tangkijvanich P
    BMC Med Genet; 2019 May; 20(1):87. PubMed ID: 31117968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymorphisms in sodium taurocholate cotransporting polypeptide are not associated with hepatitis B virus clearance in Chinese Tibetans and Uygurs.
    Su Z; Li Y; Liao Y; Cai B; Chen J; Zhang J; Li L; Ying B; Tao C; Zhao M; Ba Z; Zhang Z; Wang L
    Infect Genet Evol; 2016 Jul; 41():128-134. PubMed ID: 27051045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of Ser267Phe variant of sodium taurocholate cotransporting polypeptide among Moroccans regardless of hepatitis B virus infection status.
    Ezzikouri S; Chihab H; Elhabazi A; Wakrim L; Benjelloun S
    BMC Infect Dis; 2017 Jan; 17(1):99. PubMed ID: 28125961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The p.Ser267Phe variant of sodium taurocholate cotransporting polypeptide (NTCP) supports HBV infection with a low efficiency.
    Liu C; Xu G; Gao Z; Zhou Z; Guo G; Li D; Jing Z; Sui J; Li W
    Virology; 2018 Sep; 522():168-176. PubMed ID: 30032030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NTCP gene polymorphisms and hepatitis B virus infection status in a Ghanaian population.
    Nyarko E; Obirikorang C; Owiredu WKBA; Adu EA; Acheampong E; Aidoo F; Ofori E; Addy BS; Asare-Anane H
    Virol J; 2020 Jul; 17(1):91. PubMed ID: 32620148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of hepatitis B virus preS1 variability and prevalence of the rs2296651 polymorphism in a Spanish population.
    Casillas R; Tabernero D; Gregori J; Belmonte I; Cortese MF; González C; Riveiro-Barciela M; López RM; Quer J; Esteban R; Buti M; Rodríguez-Frías F
    World J Gastroenterol; 2018 Feb; 24(6):680-692. PubMed ID: 29456407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Viral entry of hepatitis B and D viruses and bile salts transportation share common molecular determinants on sodium taurocholate cotransporting polypeptide.
    Yan H; Peng B; Liu Y; Xu G; He W; Ren B; Jing Z; Sui J; Li W
    J Virol; 2014 Mar; 88(6):3273-84. PubMed ID: 24390325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The rs2296651 (S267F) variant on NTCP (SLC10A1) is inversely associated with chronic hepatitis B and progression to cirrhosis and hepatocellular carcinoma in patients with chronic hepatitis B.
    Hu HH; Liu J; Lin YL; Luo WS; Chu YJ; Chang CL; Jen CL; Lee MH; Lu SN; Wang LY; You SL; Yang HI; Chen CJ;
    Gut; 2016 Sep; 65(9):1514-21. PubMed ID: 26642861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of the S267F variant on NTCP gene and treatment response to pegylated interferon in patients with chronic hepatitis B: a multicentre study.
    Thanapirom K; Suksawatamnuay S; Sukeepaisarnjaroen W; Treeprasertsuk S; Tanwandee T; Charatcharoenwitthaya P; Thongsawat S; Leerapun A; Piratvisuth T; Boonsirichan R; Bunchorntavakul C; Pattanasirigool C; Pornthisarn B; Tuntipanichteerakul S; Sripariwuth E; Jeamsripong W; Sanpajit T; Poovorawan Y; Komolmit P
    Antivir Ther; 2018; 23(1):67-75. PubMed ID: 28635613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of the gene polymorphisms in sodium taurocholate cotransporting polypeptide with the outcomes of hepatitis B infection in Chinese Han population.
    Su Z; Li Y; Liao Y; Cai B; Chen J; Zhang J; Li L; Ying B; Tao C; Wang L
    Infect Genet Evol; 2014 Oct; 27():77-82. PubMed ID: 25010264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis B virus infection in Taiwan: The role of NTCP rs2296651 variant in relation to sex.
    Nfor ON; Wu MF; Debnath T; Lee CT; Lee W; Liu WH; Tantoh DM; Hsu SY; Liaw YP
    J Viral Hepat; 2018 Oct; 25(10):1116-1120. PubMed ID: 29660219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Loss-of-Function S267F Variant in HBV Receptor NTCP Reduces Human Risk for HBV Infection and Disease Progression.
    An P; Zeng Z; Winkler CA
    J Infect Dis; 2018 Sep; 218(9):1404-1410. PubMed ID: 29905807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relationship between NTCP gene varieties and the progress of liver disease after HBV infection: an updated systematic review and meta-analysis.
    He C; He HY; Sun CF; Ojha SC; Wang H; Deng CL; Sheng YJ
    Am J Med Sci; 2022 Aug; 364(2):207-219. PubMed ID: 35398032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NTCP S267F variant associates with decreased susceptibility to HBV and HDV infection and decelerated progression of related liver diseases.
    Binh MT; Hoan NX; Van Tong H; Sy BT; Trung NT; Bock CT; Toan NL; Song LH; Bang MH; Meyer CG; Kremsner PG; Velavan TP
    Int J Infect Dis; 2019 Mar; 80():147-152. PubMed ID: 30685591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of S267F variant of NTCP on the patients with chronic hepatitis B.
    Lee HW; Park HJ; Jin B; Dezhbord M; Kim DY; Han KH; Ryu WS; Kim S; Ahn SH
    Sci Rep; 2017 Dec; 7(1):17634. PubMed ID: 29247233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NTCP polymorphisms were associated with fibrosis development in patients with chronic HBV infection.
    Su Z; Cai B; Wu X; Li L; Wei B; Meng L; Wang L; Wang L
    J Infect Dev Ctries; 2022 Jan; 16(1):179-186. PubMed ID: 35192536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SLC10A1 rs2296651 variant (S267F mutation) predicts biochemical traits, hepatitis B virus infection susceptibility and the risk of gallstone disease.
    Ko YL; Tuan WL; Teng MS; Su WC; Wang CC; Er LK; Wu S; Hsu LA
    Mol Genet Genomics; 2024 Jun; 299(1):62. PubMed ID: 38869622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diverse Effects of the NTCP p.Ser267Phe Variant on Disease Progression During Chronic HBV Infection and on HBV preS1 Variability.
    Yang F; Wu L; Xu W; Liu Y; Zhen L; Ning G; Song J; Jiao Q; Zheng Y; Chen T; Xie C; Peng L
    Front Cell Infect Microbiol; 2019; 9():18. PubMed ID: 30881922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The p.Ser267Phe variant in SLC10A1 is associated with resistance to chronic hepatitis B.
    Peng L; Zhao Q; Li Q; Li M; Li C; Xu T; Jing X; Zhu X; Wang Y; Li F; Liu R; Zhong C; Pan Q; Zeng B; Liao Q; Hu B; Hu ZX; Huang YS; Sham P; Liu J; Xu S; Wang J; Gao ZL; Wang Y
    Hepatology; 2015 Apr; 61(4):1251-60. PubMed ID: 25418280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.